The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney Week 2023 November 1–November 5.
Researchers in São Paulo state, Brazil, have developed a low-cost anti-inflammatory hydrogel that in future could help treat chronic skin lesions such as those often seen in people with diabetes.
The US Food and Drug Administration has approved Ardelyx s drug to treat high phosphate levels in patients with chronic kidney disease, the company said, more than 2 years after it was initially rejected.
Novo Nordisk will stop a trial studying Ozempic to treat kidney failure in patients with diabetes ahead of schedule because it was clear from an interim analysis that the treatment would succeed.